Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Jennifer Buell
Person

Jennifer Buell

Tracked across 3 events · 24 articles · First seen Apr 03, 2026 · Last active Aug 06, 2026

Sentiment
30
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 60
Tech
MiNK Therapeutics Doses First Patient
Impact: As President and CEO of MiNK Therapeutics, Jennifer Buell's statements highlight the importance of this clinical trial for critical illness, reinforcing the company's commitment to addressing unmet medical needs.
May 28, 2026 · 6 articles
4 30
Tech
MiNK Therapeutics agenT-797 Phase II Data
Impact: Jennifer Buell, President and CEO of MiNK Therapeutics, provided commentary on the positive trial results and the potential of agenT-797.
Apr 03, 2026 · 12 articles
4 0
Tech
MiNK agenT-797 Phase 2 pneumonia data
Impact: Jennifer Buell, CEO of MiNK, highlighted the rapid trial activation and the therapy's off-the-shelf advantages, supporting the company's strategic narrative.
Aug 06, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Jennifer Buell live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.